Upstream Bio (UPB) Current Leases (2023 - 2026)
Upstream Bio (UPB) recorded quarterly Current Leases of $724000.0 in Q1 2026, up 0.56% quarter-over-quarter from $720000.0 in Q4 2025, and up 2.26% on a YoY basis from $708000.0 in Q1 2025.
Upstream Bio (UPB) Current Leases (2023 - 2026) Analysis & Trends
Upstream Bio's Current Leases history runs 4 years deep, the most recent figure standing at $724000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 2.26% year-over-year to $724000.0; the TTM figure through Mar 2026 stood at $724000.0 (up 2.26% YoY), while the FY2025 annual figure was $720000.0, up 2.27% from the prior year.
- Current Leases was $724000.0 for Q1 2026 at Upstream Bio, up from $720000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $724000.0 in Q1 2026 to a low of $45000.0 in Q4 2023.
- Historically, Current Leases has averaged $625875.0 across 4 years, with a median of $710000.0 in 2025.
- The sharpest annual moves came in 2024 and 2026: Current Leases jumped 1464.44% in 2024, then increased 2.26% in 2026.
- A 4-year view of Current Leases shows it stood at $45000.0 in 2023, then surged by 1464.44% to $704000.0 in 2024, then grew by 2.27% to $720000.0 in 2025, then increased by 0.56% to $724000.0 in 2026.
- The last three Current Leases figures came in at $724000.0 (Q1 2026), $720000.0 (Q4 2025), and $716000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Upstream Bio | 339.03 Mn | 339.03 Mn | -3.94 Mn | 724,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 724,000.00 |
| Dec 31, 2025 | 720,000.00 |
| Sep 30, 2025 | 716,000.00 |
| Jun 30, 2025 | 712,000.00 |
| Mar 31, 2025 | 708,000.00 |
| Dec 31, 2024 | 704,000.00 |
| Sep 30, 2024 | 678,000.00 |
| Dec 31, 2023 | 45,000.00 |